BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Infectious Disease Research Institute (IDRI) 

1124 Columbia Street
Suite 400
Seattle  Washington  98104  U.S.A.
Phone: 206-381-0883 Fax: 206-381-3678


SEARCH JOBS










 Company News
Infectious Disease Research Institute (IDRI) and Zydus Sign Agreement for Development of IDRI's Vaccine Candidate for Visceral Leishmaniasis (Kala-Azar) 7/25/2013 9:52:03 AM    More...
Infectious Disease Research Institute (IDRI) and Medicago, Inc. Report Positive Results for Phase I Clinical Trial for an H5N1 Vaccine 4/18/2013 9:23:50 AM    More...
Infectious Disease Research Institute (IDRI) and Medicago, Inc. to Present Data at the World Vaccine Congress 4/9/2013 6:48:19 AM    More...
Infectious Disease Research Institute (IDRI) and Medicago, Inc. Announce FDA Authorization to Initiate a Phase 1 Clinical Trial for an H5N1 Vaccine With GLA Adjuvant 8/16/2012 10:20:05 AM    More...
Infectious Disease Research Institute (IDRI) Expands Board, Adding Additional International Expertise With Dr Massimo Radaelli 7/3/2012 9:59:17 AM    More...
Soligenix (SNGX.OB) Announces Collaboration with Infectious Disease Research Institute (IDRI) to Develop Thermostabilized Biodefense Vaccines Utilizing Novel Adjuvants 6/27/2012 9:40:52 AM    More...
Infectious Disease Research Institute (IDRI) Signs Lease with Alexandria Real Estate Equities, Inc. for New Seattle Headquarters 5/31/2012 11:10:18 AM    More...
Aeras Global TB Vaccine Foundation and Infectious Disease Research Institute (IDRI) Sign Agreement to Jointly Develop Novel Tuberculosis Vaccine 5/10/2012 10:06:47 AM    More...
Infectious Disease Research Institute (IDRI) Quest for Leprosy Vaccine Closer to Reality With Help of Million Dollar Grant 3/8/2012 11:00:37 AM    More...
Infectious Disease Research Institute (IDRI) Release: First Vaccine Against Fatal Visceral Leishmaniasis Enters Clinical Trial 2/23/2012 10:26:23 AM    More...
1234